(69 days)
Pillar Prolastic Sheeting, SupraFOIL, Seare Silicone Sheeting, Durasil I and Durasil II, Specialty Surgery Silicone Elastomer, Lactosorb Ethmoid Stent, and MacroPore Protego System
Not Found
No
The device description focuses on the material properties and physical characteristics of a resorbable implant, with no mention of software, algorithms, or data processing that would indicate AI/ML.
Yes.
The device is used for surgical repair and reconstruction in the ear, nose, and throat, which directly addresses medical conditions and aims to restore normal function.
No
The device is described as a resorbable implant used for surgical repair and reconstruction of various ENT structures. Its intended uses are therapeutic (repairing and preventing adhesions), not diagnostic.
No
The device is a physical implant made of poly lactic acid (PLA) in sheet form, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes surgical applications for repairing and reconstructing tissues in the ear, nose, and throat. This involves direct interaction with the patient's body during a surgical procedure.
- Device Description: The device is a resorbable implant designed to be physically placed within the body. It is shaped, heated, and manipulated for surgical placement.
- Lack of In Vitro Diagnostic Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples) outside of the body to provide information for diagnosis, monitoring, or screening.
IVD devices are used to perform tests on samples taken from the body, while this device is a surgical implant used within the body.
N/A
Intended Use / Indications for Use
The MacroPore ENT Reconstruction Film is indicated for the following surgical applications:
- 1). Tympanic membrane repair.
- 2). Tympanoplasty in the middle ear.
- 3). Nasal splinting and surgical repair of nasal septum.
- 4). Guided tissue regeneration of the external ear.
- 5). Prevents adhesions between the septum and the nasal cavity.
Product codes (comma separated list FDA assigned to the subject device)
NHB, LYA
Device Description
MacroPore ENT Reconstruction Film is a resorbable implant in sheet form manufactured from poly lactic acid (PLA). MacroPore ENT Reconstruction Film can be cut with scissors to the desired shape and size. The MacroPore Power Pen can also be used to cut or shape the MacroPore ENT Reconstruction Film to the desired shape or size.
MacroPore ENT Reconstruction Film Sheet is fully malleable when heated to approximately 55°C (for example, by the use of sterile hot water), and thus can be conformed three dimensionally to most any anatomical orientation. The MacroPore ENT Reconstruction Film can be rolled into a tube or used as a flat sheet. It can be used either alone or in conjunction with soft tissue fixation devices such as resorbable sutures, which also can serve to fixate the MacroPore ENT Reconstruction Film and prevent dislocation. The MacroPore ENT Reconstruction Film may be used in conjunction with various MacroPore manual instruments.
MacroPore ENT Reconstruction Film is provided in various shapes such as rectangles, ovals, and circles and will be provided in other shapes and sizes as needed for particular surgical procedures. MacroPore ENT Reconstruction Film is provided in sheets of 10mm x 10mm to 120mm x 120mm and will be provided in other shapes and sizes as needed for particular surgical procedures. The thickness of the MacroPore ENT Reconstruction Film ranges from 0.02 mm to 2.0 mm according to the region to be treated. The MacroPore ENT Reconstruction Film is provided with and without macroporous holes. The macroporous holes range in size from 50 microns to 3,000 microns in diameter and may be in aligned, offset, or random patterns. The borders of the sheets may be aligned with holes to attach suture material.
Material Composition: The MacroPore ENT Reconstruction Film is fabricated from polylactic acid (PLA).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Tympanic membrane, middle ear, nasal septum, external ear, nasal cavity.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
In Vitro Testing:
- Testing was performed to determine the effect of prolonged heating in saline at 60°C on inherent viscosity. Results demonstrated that viscosity stayed within an appropriate range over 120 minutes.
- Aging testing was performed, demonstrating that the MacroPore ENT Reconstruction Film is strong enough for the indications for use.
- Mechanical testing was performed, determining the MacroPore ENT Reconstruction Film to be substantially equivalent to the mechanical strengths of the predicate devices under indication for use conditions.
In Vivo Testing:
- An animal study was conducted to demonstrate safety and efficacy of the MacroPore ENT Reconstruction Film. The animal studies demonstrated that the MacroPore ENT Reconstruction Film materials are appropriate for the indications for use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Pillar Prolastic Sheeting, SupraFOIL, Seare Silicone Sheeting, Durasil I and Durasil II, Specialty Surgery Silicone Elastomer, Lactosorb Ethmoid Stent, and MacroPore Protego System
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.3620 Ear, nose, and throat synthetic polymer material.
(a)
Identification. Ear, nose, and throat synthetic polymer material is a device material that is intended to be implanted for use as a space-occupying substance in the reconstructive surgery of the head and neck. The device is used, for example, in augmentation rhinoplasty and in tissue defect closures in the esophagus. The device is shaped and formed by the suregon to conform to the patient's needs. This generic type of device is made of material such as polyamide mesh or foil and porous polyethylene.(b)
Classification. Class II.
0
OCT 2 5 2001
019769
MacroPore ENT Reconstruction Film Page 1 of 3 510(k) SUMMARY
ADMINISTRATIVE INFORMATION
Manufacturer Name:
Official Contact:
MacroPore, Inc. 6740 Top Gun Street San Diego, CA 92121
Kenneth K. Kleinhenz Director of Regulatory Affairs Telephone (858) 458-0900 Fax (858) 458-0994
DEVICE NAME
Classification Name:
Ear, nose, and throat synthetic polymer material
Trade/Proprietary Name:
MacroPore ENT Reconstruction Film
ESTABLISHMENT REGISTRATION NUMBER 2031733
DEVICE CLASSIFICATION AND PRODUCT CODE
As shown in 21CFR 874.3620, Ear, nose, and throat synthetic polymer materials are synthetic AS shown in 21 21 cr of 1.50by bed, for use as a space-occupying substance in reconstructive surgery procedures of the head and neck. The device is intended to be shaped and formed by the surgeon to conform to the patient's needs. These devices are classified as Class II. Ear, nose, and throat synthetic polymer materials have been assigned Product Code NHB.
INTENDED USE
The MacroPore ENT Reconstruction Film is indicated for the following surgical applications:
- 1). Tympanic membrane repair.
- 2). Tympanoplasty in the middle car.
- 3). Nasal splinting and surgical repair of nasal septum.
- 4). Guided tissue regeneration of the external ear.
- 5). Prevents adhesions between the septum and the nasal cavity
1
DEVICE DESCRIPTION
Design Characteristics
MacroPore ENT Reconstruction Film is a resorbable implant in sheet form manufactured from poly lactic acid (PLA). MacroPore ENT Reconstruction Film can be cut with scissors to the desired shape and size. The MacroPore Power Pen can also be used to cut or shape the MacroPore ENT Reconstruction Film to the desired shape or size.
MacroPore ENT Reconstruction Film Sheet is fully malleable when heated to approximately 55°C (for example, by the use of sterile hot water), and thus can be conformed three dimensionally to most any anatomical orientation. The MacroPore ENT Reconstruction Film can be rolled into a tube or used as a flat sheet. It can be used either alone or in conjunction with soft tissue fixation devices such as resorbable sutures, which also can serve to fixate the MacroPore ENT Reconstruction Film and prevent dislocation. The MacroPore ENT Reconstruction Film may be used in conjunction with various MacroPore manual instruments.
MacroPore ENT Reconstruction Film is provided in various shapes such as rectangles, ovals, and circles and will be provided in other shapes and sizes as needed for particular surgical procedures. MacroPore ENT Reconstruction Film is provided in sheets of 10mm x 10mm to 120mm x 120mm and will be provided in other shapes and sizes as needed for particular surgical procedures. The thickness of the MacroPore ENT Reconstruction Film ranges from 0.02 mm to 2.0 mm according to the region to be treated. The MacroPore ENT Reconstruction Film is provided with and without macroporous holes. The macroporous holes range in size from 50 microns to 3,000 microns in diameter and may be in aligned, offset, or random patterns. The borders of the sheets may be aligned with holes to attach suture material
Material Composition
The MacroPore ENT Reconstruction Film is fabricated from polylactic acid (PLA).
In Vitro Testing
Because the MacroPore ENT Reconstruction Film is intended to be heated in the surgical suite to temperatures above the material's glass transition temperature to facilitate shaping to anatomic structures, testing was performed to determine the effect of prolonged heating in saline at 60°C on inherent viscosity. The testing demonstrates that viscosity stayed within an appropriate range over 120 minutes. Therefore, the relatively brief exposure anticipated during the surgical preparation of MacroPore ENT Reconstruction Film is not expected to have a significant effect on its mechanical properties.
Aging testing was performed on MacroPore ENT Reconstruction Film. Testing demonstrated that the MacroPore ENT Reconstruction Film is strong enough for the indications for use.
Mechanical testing was performed on the MacroPore ENT Reconstruction Film which determined the MacroPore ENT Reconstruction Film to be substantially equivalent to the mechanical strengths of the predicate devices under indication for use conditions.
2
510(k) SUMMARY
In Vivo Testing
An animal study was conducted to demonstrate safety and efficacy of the MacroPore ENT An animal study was ochial. The animal studies demonstrated that the MacroPore ENT Reconstruction Film materials are appropriate for the indications for use.
EQUIVALENCE TO MARKETED PRODUCT
MacroPore ENT Reconstruction Film shares indications and design principles with the following predicate devices, which have been determined by FDA to be substantially equivalent to the Pillar Prolastic Sheeting, SupraFOIL, Seare Silicone following pre-amendment devices: Sheeting, Durasil I and Durasil II, Specialty Surgery Silicone Elastomer, Lactosorb Ethmoid Stent, and MacroPore Protego System.
Indications For Use
The MacroPore ENT Reconstruction Film shares identical indications for use principles with the The Macror of 214 "Recombile to Pore ENT Reconstruction Film and the predicate devices are indicated for the same surgical procedures.
Design and Materials
Design and MacroPore ENT Reconstruction Film and the predicate devices Pillar Prolastic Sheeting, SupraFOIL, Seare Silicone Sheeting, Durasil I and Durasil II, Specialty Fronotic Silicone Elastomer, Lactosorb Ethomoid Stent, and MacroPore Protego System) are substantially equivalent, consisting of a thin semi-rigid sheets that allow for contouring. Both the predicate devices and the MacroPore ENT Reconstruction Film have a semi-rigid construction. predicate also Reconstruction Film and the predicates also share design features of allowing for contouring. The MacroPore ENT Reconstruction Film is fully contourable when heated to for contrately 55°C. The thickness of the predicate devices and the MacroPore ENT approximatory 55 O. The are substantially equivalent as the MacroPore ENT Reconstruction Film thickness ranges are essentially a subset of the predicate ranges. The MacroPore ENT Reconstruction Film has a thickness range of .02mm - 2.0mm which is substantially equivalent to the predicate devices that range in thickness from .05mm - 2.0mm. The dimensions of the predicate device are also comparable to the MacroPore ENT Reconstruction Film as both devices produced in rectangular sheets that are several centimeters in size. The mechanical characteristics of the MacroPore ENT Reconstruction Film are also substantially equivalent to the predicate devices. In addition to physical characteristics, both the predicate device and the MacroPore ENT Reconstruction Film can be cut to specific shapes and sizes by the end user.
3
Image /page/3/Picture/1 description: The image shows a black and white logo. The logo is circular and contains an image of an eagle. The eagle is facing to the right. The text "U.S. Department of Health & Human Services" is written around the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 2 5 2001
MacroPore, Inc. c/o Kenneth K. Kleinhenz Director of Regulatory Affairs 6740 Top Gun Street San Diego, CA 92121
Re: K012769
Trade/Device Name: MicroPore ENT Reconstruction Film Regulation Number: 21 CFR 874.3620; 21 CFR 874.4780 Regulation Name: Ear Nose and Throat Synthetic Polymer Material Intranasal Splint Regulatory Class: Class II; Class I Product Code: NHB: LYA Dated: August 15, 2001 Received: August 17, 2001
Dear Mr. Kleinhenz:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
and the country of the county of
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter with anow you to obgin mailing of substantial equivalence of your device to a legally prematication. "The PDF missily sification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and If you desire specific acres 809.10 for in vitro diagnostic devices), please contact the Office of additionally 21 OF 1 F a c 613. Additionally, for questions on the promotion and advertising of Complance at (301) 591-1019 Fridaes Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division Other general international and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
A. Ralph Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
5
012769
Device Name: MacroPore ENT Reconstruction Film
Indications for Use:
and the comments of the comments
Thurcations for 'OSC.
The MacroPore ENT Reconstruction Film is indicated for the following surgical applications:
- 1). Tympanic membrane repair.
- 2). Tympanoplasty in the middle ear.
- 3). Nasal splinting and surgical repair of nasal septum.
- 4). Guided tissue regeneration of the external ear.
- 5). Prevents adhesions between the septum and the nasal cavity.
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NECESSARY) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
Division of Ophthalmic I 510(k) Number
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________